Pharmacovigilance Application Specialist, Global Pharmacovigilance Technology
Driven by research and a passion for science Ferring Pharmaceuticals is a biopharmaceutical company dedicated to the development of innovative treatments that make a real difference in people’s lives all over the world. Active in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics, we develop medicine on the body's own terms. We believe in the power of people and research - and go where ideas and research take us.
Are you willing to become confident with the importance of a safety database, its critical aspects and are you ready to release its unlocked potentials; you could be just the right candidate for the job as PV Application Specialist at Ferring. Maintaining the highest standards, you will contribute taking us to the next level where technology is one of the central capabilities to ensure continued growth and success.
Global Pharmacovigilance (GPV) has been growing significantly and we are now more than 40 international employees responsible for the surveillance of all Ferring medicinal products and devices. Pharmacovigilance Technology (PV Tech) is a staff function in Global Pharmacovigilance currently with 3 FTEs. The PV Tech team works in close collaboration with stakeholders within GPV as well as internally within Ferring.
The work in our department is carried out in the mindset of the Ferring Philosophy; trust, integrity, commitment and openness. This means that our leadership philosophy is identified by great enthusiasm that contributes to the management and continuous development of GPV, its employees, Ferring’s products and business processes. We offer a challenging and exciting job in an international company with great development possibilities, an entrepreneurial and open work environment.
You manage critical patient safety applications.
As PV Application Specialist you will be responsible for managing PV applications that are critical for Ferring and our patient’s safety. Further you ensure that the applications always are in compliance and that we utilize our technologies in the best possible way.
It will be expected that you take up the responsibility, of both leading and acting as a subject matter expert on the tasks and projects you are assigned to, where it is essential that you can:
Identify the IT enhancements and opportunities for the PV process
Develop creative application and report solutions
Bring forward business and end-user requests from requirement, design, test and deployment to meet the process needs
Provide strategic input to the safety database system owner and IT demand plan
Be an expert as 2nd line application supporter including direct contact to the software vendors
You will have a visible role making sure that our applications support our need for consistent, correct and valid documentation of our case processing. You are prepared to take up a position in a team with challenging tasks and plenty of opportunities, for you to exploit your full potential and professional competencies.
QUALIFICATIONSSpecialist with patience and accurateness.
The preferred candidate holds a degree in Computer Science or a comparable educational background at minimum Bachelor’s level with at least 3-5 years’ of experience from a similar job. Possibly familiar with best practise as ITIL, GAMP 5 and GxP, as well experience from the pharmaceutical industry or equivalent where quality matters.
In your daily work, you thrive for a high standard of documentation and are skilled in analytics of computerised systems. It is essential that you acknowledge the importance of accuracy and a quick-fix is a no-go, and patience sometimes is our only weapon to complete a task. In the daily work you are expected to communicate clear and timely in a professional manner – also in English.
Further information can be obtained by contacting Head of PV Tech, Stefan Knold via phone +45 2878 7251. Use apply button to submit your application! Your application and CV in English should be sent no later than October 9, 2016.